Телефон
Today, the HETERO Group of Companies in Russia sets itself the goal of providing citizens of the Russian Federation, the EAEU and other partner countries with modern high-quality drugs for the treatment of HIV, hepatitis, tuberculosis, cancer and other diseases; increasing the availability of high-quality and effective treatment of patients with modern drugs and organizing a full production cycle based on Russian production facilities.
The main production site of the HETERO Group of Companies - MAKIZ-PHARMA LLC since 2000 has had a technological platform that meets international standards in the field of drug production, and is located in Moscow.
In the shortest possible time, the HETERO Group of Companies plans to implement a full production cycle in Russia (from the synthesis of pharmaceutical substances to the manufacture of finished dosage forms) at the new production site of the HETERO Group of Companies in Russia - a pharmaceutical enterprise located in the Tula Region.
The main production site of the HETERO Group of Companies - MAKIZ-PHARMA LLC since 2000 has had a technological platform that meets international standards in the field of drug production, and is located in Moscow.
In the shortest possible time, the HETERO Group of Companies plans to implement a full production cycle in Russia (from the synthesis of pharmaceutical substances to the manufacture of finished dosage forms) at the new production site of the HETERO Group of Companies in Russia - a pharmaceutical enterprise located in the Tula Region.
